AKT1 and ovarian carcinoma: Increased AKT phosphorylation following TTFields application was observed in all examined models: N1-S1 hepatocellular carcinoma (HCC), MOSE-L ovarian cancer, and LL/2 lung tumors (Fig. 1E).